Skip to main content
AmigoFish

Highlights From the American College of Cardiology's 2026 Scientific Sessions

From JAMA Medical News · · 20 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

Hear the latest on PCSK9 inhibitors, cardiorenal benefits of GLP-1 drugs, and other clinical research in this interview with Katie Berlacher, MD, MS, chair of this year's annual ACC meeting. Related Content:

- PCSK9 Inhibitors in Diabetes, Tirzepatide's Cardiorenal Effects, Shingles Vaccine, and More From ACC

Back to JAMA Medical News · Report a problem